The enantio‐ and chemoselective iridium‐catalyzed N‐allylation of oximes is described for the first time. Intramolecular kinetic resolution provides access to cyclic nitrones and enantioenriched aliphatic allylic alcohols. Salient features of th...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=O106430060
2021년
eng
1433-7851
1521-3773
SCI;SCIE;SCOPUS
학술저널
Angewandte Chemie international edition
9913-9918 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
The enantio‐ and chemoselective iridium‐catalyzed N‐allylation of oximes is described for the first time. Intramolecular kinetic resolution provides access to cyclic nitrones and enantioenriched aliphatic allylic alcohols. Salient features of th...
The enantio‐ and chemoselective iridium‐catalyzed N‐allylation of oximes is described for the first time. Intramolecular kinetic resolution provides access to cyclic nitrones and enantioenriched aliphatic allylic alcohols. Salient features of this transformation are its ability to employ E/Z‐isomeric mixtures of oxime starting materials convergently and high functional group tolerance. The implementation of N‐allylation/1,3‐dipolar cycloaddition reaction sequences furnishes tricyclic isoxazolidines in highly enantio‐ and diastereoselective fashion. The synthetic utility of the approach is demonstrated by the efficient, formal synthesis of the marine natural product (+)‐halichlorine.
The iridium‐catalyzed intramolecular chemo‐ and enantioselective N‐allylation of oximes is reported. The method employs E/Z mixtures of oximes and furnishes cyclic nitrones with high enantioselectivity. Tandem N‐allylation/dipolar cycloaddition sequences provide access to enantioenriched tricyclic isoxazolidines and enable the formal synthesis of the marine natural product Halichlorine.
Discovery of Cyanobacterial Natural Products Containing Fatty Acid Residues**
Oxidative‐Species‐Selective Materials for Diagnostic and Therapeutic Applications
Molecular Insights into Small‐Molecule Drug Discovery for SARS‐CoV‐2